Skip to main content
Matsuya R&D Co.,Ltd logo

Matsuya R&D Co.,Ltd — Investor Relations & Filings

Ticker · 7317 ISIN · JP3869400006 T Manufacturing
Open in API
Filings indexed 47 across all filing types
Latest filing 2026-05-19 M&A Activity
Country JP Japan
Listing T 7317

About Matsuya R&D Co.,Ltd

https://www.matsuyard.co.jp/en

Matsuya R&D Co., Ltd. specializes in the development, manufacture, and sale of automated sewing systems, including sewing robots. The company operates a unique business model that combines the sale of its proprietary automation equipment with OEM contract manufacturing services that utilize these same technologies. This dual approach provides tailored solutions that enhance production quality, improve efficiency, and address labor shortages for clients. Key focus areas include the mobility and medical sectors. In mobility, the company provides stitching systems for automotive safety devices, such as airbags, and interior components. For the medical field, it develops automated production lines for hygiene products and protective clothing, as well as rehabilitation robots. The company also serves other industries, including furniture and textiles.

Recent filings

Filing Released Lang Actions
意見表明報告書
M&A Activity Classification · 90% confidence The document is a Japanese “意見表明報告書” filed with the Kanto Local Finance Bureau in connection with a public tender offer (公開買付け) by Omron Healthcare Co., Ltd. It provides the target company’s board opinion, detailed terms of the takeover offer, conditions, defense measures and process, and references to related agreements. This falls squarely under M&A Activity (takeover bid) rather than an earnings release or management report. Therefore, it should be classified as M&A Activity (TAR).
2026-05-19 Japanese
オムロンヘルスケア株式会社による当社株券等に対する公開買付けに関する 賛同の意見表明及び応募推奨のお知らせ
M&A Activity Classification · 95% confidence The document is a Japanese press release notifying shareholders of the company’s board resolution to express support and recommend participation in a public tender offer (“公開買付け”) by Omron Healthcare to make the company a wholly owned subsidiary. It details the tender offer structure, background, conditions, and board opinions. This is clearly an M&A-related announcement (a takeover bid) rather than a financial report, management change, or other regulatory update. Thus the correct category is M&A Activity (TAR).
2026-05-18 Japanese
臨時報告書
Regulatory Filings Classification · 80% confidence The document is a Japanese “臨時報告書” (extraordinary/timely disclosure report) filed under the Financial Instruments and Exchange Act (Article 24-5) to report a material event (receipt of a $5 million dividend from a foreign subsidiary). It is not an annual or interim report, not a dividend payment announcement to shareholders, and not a management or audit report. It is a regulatory filing with the authorities, falling under the fallback Regulatory Filings category.
2026-04-15 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the 'Interim Report' (Hankishohokokusho) for the period ending September 30, 2025. Since this is a regulatory filing required by law to accompany financial reports but is not the financial report itself, and does not fit into specific categories like AGM or M&A, it falls under the general regulatory filing category.
2025-11-10 Japanese
半期報告書－第44期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (半期報告書) filed with the Hokuriku Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, for the interim period ending September 30, 2025. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-10 Japanese
臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) in the header section and explicitly states it is filed based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related regulations. The content details a specific, significant event: receiving a dividend of $3,500,000 USD from an overseas subsidiary, which is expected to impact the non-operating income in the non-consolidated financial statements for the fiscal year ending March 2026. This structure—a formal filing reporting a material event that significantly impacts financial status or results—is characteristic of a major event disclosure. Since it is not a standard periodic report (10-K, IR) or a simple announcement of a report release (RPA), and it deals with a specific financial event (dividend receipt impacting results), it fits best under the general 'Regulatory Filings' category (RNS) as a catch-all for mandatory, non-standard disclosures, or potentially 'DIV' if the focus was purely on the dividend announcement, but the context is a formal regulatory filing about the financial impact. Given the formal structure and the nature of reporting a significant event under specific financial regulations, RNS (Regulatory Filings) is the most appropriate general classification when a more specific code like DIV (Notice of Dividend Amount) doesn't fully capture the regulatory filing nature of the entire document, although the event is a dividend. However, since the event is the *receipt* of a dividend impacting financials, and there is no specific code for 'Material Event Disclosure' outside of the standard periodic reports, RNS serves as the best fit for this type of mandatory, non-scheduled regulatory submission.
2025-07-15 Japanese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.